IMMUNOTHERAPEUTIC SIGNIFICANCE OF NTPASE 8 IN ONCOLOGY

This article explores the immunotherapeutic significance of the enzyme NTPDase 8 in oncology. In recent years, immunotherapy has emerged as a promising approach in the fight against cancer, highlighting the growing need to understand the complex interactions within the tumor microenvironment (TME). NTPDase 8 belongs to the family of ectonucleotidases involved in the metabolism of extracellular nucleotides and is predominantly expressed in the liver. The article discusses in detail the role of NTPDase 8 in cancer biology, its immunomodulatory functions, and its potential as a therapeutic target in cancer immunotherapy. Additionally, the pharmacological modulation of NTPDase 8 and directions for future research are considered. In conclusion, NTPDase 8 represents a promising target in cancer immunotherapy, and its further investigation may contribute to the development of novel targeted therapeutic strategies